Studies on the ability of compounds to block the diabetogenic activity of streptozotocin.
D000596:Amino Acids / Q000494:pharmacology; D000818:Animals; D003920:Diabetes Mellitus / Q000139:chemically induced* / Q000517:prevention & control; D003964:Diaphragm / Q000378:metabolism; D003981:Diazoxide / Q000494:pharmacology; D004837:Epinephrine / Q000494:pharmacology; D000431:Ethanol / Q000494:pharmacology; D005944:Glucosamine / Q000037:antagonists & inhibitors*; D005947:Glucose / Q000378:metabolism / Q000494:pharmacology; D006943:Hyperglycemia / Q000139:chemically induced; D007004:Hypoglycemic Agents / Q000494:pharmacology*; D008297:Male; D009243:NAD / Q000494:pharmacology; D009536:Niacinamide / Q000494:pharmacology; D009603:Nitroso Compounds / Q000037:antagonists & inhibitors*; D011718:Pyrazinamide / Q000494:pharmacology; D011719:Pyrazines / Q000494:pharmacology; D011720:Pyrazoles / Q000494:pharmacology; D051381:Rats; D014044:Tolbutamide / Q000494:pharmacology
D000596:Amino Acids; D007004:Hypoglycemic Agents; D009603:Nitroso Compounds; D011719:Pyrazines; D011720:Pyrazoles; D009243:NAD; D009536:Niacinamide; D011718:Pyrazinamide; D000431:Ethanol; D014044:Tolbutamide; D005947:Glucose; D005944:Glucosamine; D003981:Diazoxide; D004837:Epinephrine